Publications

2022

312.
Hassin O. & Oren M. (2022) Nature reviews. Drug discovery. p. 1-18  Abstract
311.
Hassin O., Nataraj N. B., Shreberk-Shaked M. et al. (2022) Nature Communications. 13, 1, 2800.  Abstract [All authors]
310.
Mukherjee S., Maddalena M., Lü Y. et al. (2022) Proceedings of the National Academy of Sciences - PNAS. 119, 17, e211964411.  Abstract [All authors]
309.
Tuval A., Brilon Y., Azogy H. et al. (2022) Haematologica (Roma). 107, 11,  Abstract [All authors]

2021

308.
Maddalena M., Mallel G., Nataraj N. B. et al. (2021) Proceedings of the National Academy of Sciences - PNAS. 118, 23, e202563111.  Abstract [All authors]
307.
Ghosh S., Nataraj N. B., Noronha A. et al. (2021) Cell reports (Cambridge). 35, 8, 109181.  Abstract [All authors]

2020

306.
Shreberk-Shaked M., Dassa B., Sinha S. et al. (2020) Cancer Research. 80, 19, p. 4145-4157  Abstract [All authors]
305.
Hoshino A., Kim H. S., Bojmar L. et al. (2020) Cell. 182, 4, p. 1044-1061.e18  Abstract [All authors]
304.
Kadosh E., Snir-Alkalay I., Venkatachalam A. et al. (2020) Nature. 7827, p. 133-+  Abstract [All authors]
303.
Benor G., Fuks G., Chin S. et al. (2020) Molecular Oncology. 14, 8, p. 1640-1652  Abstract [All authors]

2019

302.
Oren M. (2019) Journal of Molecular Cell Biology. 11, 7, p. 539-543  Abstract
301.
Shreberk-Shaked M. & Oren M. (2019) Molecular Oncology. 13, 6, p. 1335-1341  Abstract
300.
Hooda J., Novak M., Salomon M. P. et al. (2019) Cancer Research. 79, 4, p. 760-772  Abstract [All authors]

2018

299.
Furth N., Pateras I. S., Rotkopf R. et al. (2018) Life science alliance. 1, 5, 201800171.  Abstract [All authors]
298.
Minzel W., Venkatachalam A., Fink A. et al. (2018) Cell. 175, 1, p. 171-185  Abstract [All authors]
297.
Kotler E., Segal E. & Oren M. (2018) Molecular & cellular oncology. 5, 6, 1511207.  Abstract
296.
Kotler E., Shani O., Goldfeld G. et al. (2018) Molecular Cell. 71, 1, p. 178-190.e8  Abstract [All authors]
295.
Arandkar S., Furth N., Elisha Y. et al. (2018) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 115, 25, p. 6410-6415  Abstract [All authors]
294.
, Jethwa A., Slabicki M. et al. (2018) Blood. 131, 25, p. 2789-2802  Abstract [All authors]
293.
Ghannam-Shahbari D., Jacob E., Kakun R. R. et al. (2018) Oncogene. 37, 17, p. 2213-2224  Abstract [All authors]
292.
Solomon H., Dinowitz N., Pateras I. S. et al. (2018) Oncogene. 37, 12, p. 1669-1684  Abstract [All authors]
291.
, Galluzzi L., Vitale I. et al. (2018) Cell Death and Differentiation. 25, 3, p. 486-541  Abstract [All authors]
290.
Furth N., Aylon Y. & Oren M. (2018) Cell Death and Differentiation. 25, p. 81-92  Abstract

2017

289.
Enuka Y., Feldman M. E., Chowdhury A. et al. (2017) Nucleic Acids Research. 45, 22, p. 12681–12699  Abstract [All authors]
288.
Aylon Y. & Oren M. (2017) Cancer Cell. 32, 4, p. 397-399  Abstract
287.
Spolverini A., Fuchs G., Bublik D. R. & Oren M. (2017) Oncogene. 36, 42, p. 5819-5828  Abstract
286.
Tovy A., Spiro A., McCarthy R. et al. (2017) GENES & DEVELOPMENT. 31, 10, p. 959-972  Abstract
[All authors]
285.
Tarcic O., Granit R. Z., Pateras I. S. et al. (2017) Cell Death and Differentiation. 24, 4, p. 694-704  Abstract [All authors]
284.
Bublik D. R., Bursac S., Sheffer M. et al. (2017) Proceedings of the National Academy of Sciences of the United States of America. 114, 4, p. E496-E505  Abstract [All authors]

2016

283.
p53 mutations promote proteasomal activity
Oren M. & Kotler E. (2016) Nature Cell Biology. 18, 8, p. 833-835  Abstract
282.
Stock K., Estrada M. F., Vidic S. et al. (2016) Scientific Reports. 6, 28951.  Abstract [All authors]
281.
Aylon Y. & Oren M. (2016) Cell cycle (Georgetown, Tex.). 15, 17, p. 2248-55  Abstract
280.
Orsolic I., Jurada D., Pullen N., Oren M., Eliopoulos A. G. & Volarevic S. (2016) Seminars in Cancer Biology. 37-38, p. 36-50  Abstract
279.
Oren M., Tal P. & Rotter V. (2016) AGING-US. 8, 6, p. 1159-1160  Abstract
278.
Yaeger R., Shah M. A., Miller V. A. et al. (2016) Gastroenterology. 151, 2, p. 278-287.e6  Abstract [All authors]
277.
Aylon Y., Gershoni A., Rotkopf R. et al. (2016) GENES & DEVELOPMENT. 30, 7, p. 786-97  Abstract [All authors]
276.
Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
Tal P., Eizenberger S., Cohen E., Goldfinger N., Pietrokovski S., Oren M. & Rotter V. (2016) Oncotarget. 7, 11, p. 11817-11837  Abstract
275.
Tarcic O., Pateras I. S., Cooks T. et al. (2016) Cell Reports. 14, 6, p. 1462-1476  Abstract [All authors]
274.
Hoffman Y., Bublik D. R., Ugalde A. P., Elkon R., Biniashvili T., Agami R., Oren M. & Pilpel Y. (2016) PLoS Genetics. p. 260-262  Abstract

2015

273.
Harel S., Ben-Moshe N., Aylon Y. et al. (2015) Cell Death and Differentiation. 22, p. 1328-1340  Abstract [All authors]
272.
Pribluda A., Elyada E., Wiener Z. et al. (2015) Cancer Cell. 27, 6, p. 877-878  Abstract
[All authors]
271.
Fuchs G., Voichek Y., Rabani M., Benjamin S., Gilad S., Amit I. & Oren M. (2015) Nature Protocols. 10, 4, p. 605-618  Abstract
270.
Golomb L., Sagiv A., Pateras I., Maly A., Krizhanovsky V., Gorgoulis V., Oren M. & Ben-Yehuda A. (2015) Cell Death and Differentiation. 22, 11, p. 1764-1774  Abstract
269.
Furth N., Bossel Ben-Moshe B. N., Pozniak Y., Porat Z., Geiger T., Domany E., Aylon Y. & Oren M. (2015) Genes and Development. 29, p. 2325-2330  Abstract
268.
Oren M. & Arundkar S. C. (2015) Leukemia. 29, 10, p. 2015-2023  Abstract

2014

267.
Lasry A., Aran D., Zinger A. et al. (2014) Cytokine. 70, 1, p. 22-22  Abstract
[All authors]
266.
Fuchs G., Hollander D., Voichek Y., Ast G. & Oren M. (2014) Genome Research. 24, 10, p. 1572-1583  Abstract
265.
Fuchs G. & Oren M. (2014) Biochimica Et Biophysica Acta-Gene Regulatory Mechanisms. 1839, 8, p. 694-701  Abstract
264.
Cooks T., Harris C. & Oren M. (2014) Carcinogenesis. 35, 8, p. 1680-1690  Abstract
263.
Golomb L., Volarevic S. & Oren M. (2014) FEBS Letters. 588, 16, p. 2571-2579  Abstract
262.
Weilbacher A., Gutekunst M., Oren M., Aulitzky W. E. & van der Kuip d. K. H. (2014) Cell Death & Disease. 5, e1318.  Abstract
261.
Hoffman Y., Pilpel Y. & Oren M. (2014) Journal of Molecular Cell Biology. 6, 3, p. 192-197  Abstract
260.
Pathways and therapeutic targets in melanoma
Shtivelman E., Davies M. A., Hwu P., Yang J., Lotem M., Oren M., Flaherty K. T. & Fisher D. E. (2014) Oncotarget. 5, 7, p. 1701-1752  Abstract
259.
Aylon Y., Sarver A., Tovy A., Ainbinder E. & Oren M. (2014) Cell Death and Differentiation. 21, 4, p. 624-633  Abstract
258.
Hoffman Y., Bublik D. R., Pilpel Y. & Oren M. (2014) Cell Death and Differentiation. 21, 2, p. 302-309  Abstract
257.
Fuchs G., Voichek Y., Benjamin S., Gilad S., Amit I. & Oren M. (2014) GENOME BIOLOGY. 15, 5, R69.  Abstract
256.
Weingarten-Gabbay S., Khan D., Liberman N., Yoffe Y., Bialik S., Das S., Oren M. & Kimchi A. (2014) Oncogene. 33, 5, p. 611-618  Abstract

2013

255.
Fausti F., Di Agostino A. S., Cioce M. et al. (2013) Cell Death and Differentiation. 20, 11, p. 1498-1509  Abstract
[All authors]
254.
Golomb L. & Oren M. (2013) Cell Death and Differentiation. 20, 11, p. 1442-1443  Abstract
253.
Suzuki H., Yabuta N., Okada N., Torigata K., Aylon Y., Oren M. & Nojima H. (2013) Journal of Cell Science. 126, 19, p. 4358-4368  Abstract
252.
Shema E., Nikolov M., Haj-Yahya M. et al. (2013) Cell Reports. 4, 3, p. 601-608  Abstract [All authors]
251.
Pribluda A., Elyada E., Wiener Z. et al. (2013) Cancer Cell. 24, 2, p. 242-256  Abstract [All authors]
250.
Cooks T., Pateras I. S., Tarcic O. et al. (2013) Cancer Cell. 23, 5, p. 634-646  Abstract [All authors]
249.
Hoffman Y., Dahary D., Bublik D. R., Oren M. & Pilpel Y. (2013) Bioinformatics. 29, 7, p. 894-902  Abstract
248.
Gutekunst M., Mueller T., Weilbacher A., Dengler M. A., Oren M., Aulitzky W. E. & van der Kuip d. K. H. (2013)  Abstract
247.
Gutekunst M., Mueller T., Weilbacher A., Dengler M. A., Bedke J., Kruck S., Oren M., Aulitzky W. E. & van der Kuip d. K. H. (2013) Cancer Research. 73, 5, p. 1460-1469  Abstract

2012

246.
Hornung G., Bar-Ziv R., Rosin D., Tokuriki N., Tawfik D., Oren M. & Barkai N. (2012) Genome Research. 22, 12, p. 2409-2417  Abstract
245.
Bursac S., Brdovcak M. C., Pfannkuchen M. et al. (2012) Proceedings of the National Academy of Sciences of the United States of America. 109, 50, p. 20467-20472  Abstract [All authors]
244.
Schmid J. O., Dong M., Haubeiss S. et al. (2012) Cancer Research. 72, 22, p. 5824-5832  Abstract
[All authors]
243.
Fuchs G., Shema E., Vesterman R. et al. (2012) Molecular Cell. 46, 5, p. 662-673  Abstract [All authors]
242.
Hornung G., Oren M. & Barkai N. (2012) Molecular Cell. 46, 3, p. 362-368  Abstract
241.
Bublik D. R. & Oren M. (2012) EMBO Reports. 13, 4, p. 282-283  Abstract
240.
Zwang Y., Oren M. & Yarden Y. (2012) Cancer Research. 72, 5, p. 1051-1054  Abstract
239.
Blandino G., Deppert W., Hainaut P., Levine A., Lozano G., Olivier M., Rotter V., Wiman K. & Oren M. (2012) Cell Death and Differentiation. 19, 1, p. 180-183  Abstract
238.
Haj-Yahya M., Eltarteer N., Ohayon S., Shema E., Kotler E., Oren M. & Brik A. (2012) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 51, 46, p. 11535-11539  Abstract
237.
Golomb L., Bublik D. R., Wilder S., Nevo R., Kiss V., Grabusic K., Volarevic S. & Oren M. (2012) Molecular Cell. 45, 2, p. 222-232  Abstract

2011

236.
Furth N. & Oren M. (2011) Cell Cycle. 10, 18, p. 3054-3055  Abstract
235.
Shiloh Y., Shema E., Moyal L. & Oren M. (2011) FEBS Letters. 585, 18, p. 2795-2802  Abstract
234.
Golomb L. & Oren M. (2011) Cancer Cell. 20, 3, p. 283-284  Abstract
233.
Aylon Y. & Oren M. (2011) Molecular Oncology. 5, 4, p. 315-323  Abstract
232.
Tarocchi M., Hannivoort R., Hoshida Y. et al. (2011) Hepatology. 54, 2, p. 522-531  Abstract
[All authors]
231.
Shema E., Oren M. & Minsky N. (2011) Methods. 54, 3, p. 326-330  Abstract
230.
Dell'Orso S., Fontemaggi G., Stambolsky P. et al. (2011) Omics-A Journal Of Integrative Biology. 15, 5, p. 305-312  Abstract [All authors]
229.
Shema E., Kim J., Roeder R. G. & Oren M. (2011) Molecular Cell. 42, 4, p. 477-488  Abstract
228.
Zwang Y., Sas-Chen A., Drier Y. et al. (2011) Molecular Cell. 42, 4, p. 524-535  Abstract [All authors]
227.
Gutekunst M., Oren M., Weilbacher A., Dengler M. A., Markwardt C., Thomale J., Aulitzky W. E. & van der Kuip d. K. H. (2011) PLoS ONE. 6, 4,  Abstract
226.
Aylon Y. & Oren M. (2011) Current opinion in genetics & development. 21, 1, p. 86-92  Abstract
225.
Elyada E., Pribluda A., Goldstein R. E. et al. (2011) Nature. 470, 7334, p. 409-U208  Abstract [All authors]
224.
Goldstein I., Marcel V., Olivier M., Oren M., Rotter V. & Hainaut P. (2011) Cancer Gene Therapy. 18, 1, p. 2-11  Abstract
223.
Okada N., Yabuta N., Suzuki H., Aylon Y., Oren M. & Nojima H. (2011) Journal of Cell Science. 124, 1, p. 57-67  Abstract

2010

222.
Addadi Y., Moskovits N., Granot D., Lozano G., Carmi Y., Apte R. N., Neeman M. & Oren M. (2010) Cancer Research. 70, 23, p. 9650-9658  Abstract
221.
Aylon Y., Ofir-Rosenfeld Y., Yabuta N., Lapi E., Nojima H., Lu X. & Oren M. (2010) GENES & DEVELOPMENT. 24, 21, p. 2420-2429  Abstract
220.
Scherz-Shouval R., Weidberg H., Gonen C., Wilder S., Elazar Z. & Oren M. (2010) Proceedings of the National Academy of Sciences of the United States of America. 107, 43, p. 18511-18516  Abstract
219.
Nili E. L., Field Y., Lubling Y., Widom J., Oren M. & Segal E. (2010) Genome Research. 20, 10, p. 1361-1368  Abstract
218.
Shalgi R., Pilpel Y. & Oren M. (2010) Trends in Genetics. 26, 6, p. 253-259  Abstract
217.
Schilling T., Kairat A., Melino G., Krammer P. H., Stremmel W., Oren M. & Mueller M. (2010) Biochemical and Biophysical Research Communications. 394, 3, p. 817-823  Abstract
216.
Stambolsky P., Tabach Y., Fontemaggi G. et al. (2010) Cancer Cell. 17, 3, p. 273-285  Abstract [All authors]
215.
NF kappa B and p53: A life and death affair
Oren M. & Cooks T. (2010) Cell Cycle. 9, 6, p. 1027-1027  Abstract
214.
Oren M. & Rotter V. (2010) Cold Spring Harbor perspectives in biology. 2, 2,  Abstract
213.
Bar J., Moskovits N. & Oren M. (2010) SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY. 21, 1, p. 47-54  Abstract
212.
Christoffersen N. R., Shalgi R., Frankel L. B. et al. (2010) Cell Death and Differentiation. 17, 2, p. 236-245  Abstract [All authors]

2009

211.
Aylon Y., Yabuta N., Besserglick H., Buganim Y., Rotter V., Nojima H. & Oren M. (2009) Oncogene. 28, 50, p. 4469-4479  Abstract
210.
Skorta I., Oren M., Markwardt C., Gutekunst M., Aulitzky W. E. & van der Kuip d. K. H. (2009) Cancer Research. 69, 24, p. 9337-9345  Abstract
209.
Lavelin I., Beer A., Kam Z., Boner V., Oren M., Navon A. & Geiger B. (2009) PLoS ONE. 4, 12,  Abstract
208.
Levine A. J. & Oren M. (2009) Nature Reviews Cancer. 9, 10, p. 749-758  Abstract
207.
Schilling T., Schleithoff E. S., Kairat A., Melino G., Stremmel W., Oren M., Krammer P. H. & Mueller M. (2009) Biochemical and Biophysical Research Communications. 387, 2, p. 399-404  Abstract
206.
Coupling transcriptional and post-transcriptional miRNA regulation in the control of cell fate
Shalgi R., Brosh R., Oren M., Pilpel Y. & Rotter V. (2009) AGING-US. 1, 9, p. 762-770  Abstract
205.
Pirngruber J., Shchebet A., Schreiber L. et al. (2009) EMBO Reports. 10, 8, p. 894-900  Abstract [All authors]
204.
Bar J., Feniger-Barish R., Lukashchuk N. et al. (2009) Oncogene. 28, 6, p. 933-936  Abstract [All authors]

2008

203.
Brosh R., Shalgi R., Liran A. et al. (2008) Molecular Systems Biology. 4,  Abstract
[All authors]
202.
Ofir-Rosenfeld Y., Boggs K., Michael D., Kastan M. B. & Oren M. (2008) Molecular Cell. 32, 2, p. 180-189  Abstract
201.
Shema E., Tirosh I., Aylon Y. et al. (2008) GENES & DEVELOPMENT. 22, 19, p. 2664-2676  Abstract [All authors]
200.
Finkin S., Aylon Y., Anzi S., Oren M. & Shaulian E. (2008) Oncogene. 27, 32, p. 4411-4421  Abstract
199.
Bossi G., Marampon F., Maor-Aloni R., Zani B., Rotter V., Oren M., Strano S., Blandino G. & Sacchi A. (2008) Cell Cycle. 7, 12, p. 1870-1879  Abstract
198.
Minsky N., Shema E., Field Y., Schuster M., Segal E. & Oren M. (2008) Nature Cell Biology. 10, 4, p. 483-490  Abstract
197.
Abe Y., Oda-Sato E., Tobiume K., Kawauchi K., Taya Y., Okamoto K., Oren M. & Tanaka N. (2008) Proceedings of the National Academy of Sciences of the United States of America. 105, 12, p. 4838-4843  Abstract

2007

196.
Lantner F., Starlets D., Gore Y. et al. (2007) Blood. 110, 13, p. 4303-4311  Abstract
[All authors]
195.
Tiny actors, great roles - MicroRNAs in p53's service
Raver-Shapira N. & Oren M. (2007) Cell Cycle. 6, 21, p. 2656-2661  Abstract
194.
Lu X., Ma O., Nguyen T., Joness S. N., Oren M. & Donehower L. A. (2007) Cancer Cell. 12, 4, p. 342-354  Abstract
193.
Reef S., Shifman O., Oren M. & Kimchi A. (2007) Oncogene. 26, 46, p. 6677-6683  Abstract
192.
Aylon Y. & Oren M. (2007) Cell. 130, 4, p. 597-600  Abstract
191.
Shalgi R., Lieber D., Oren M. & Pilpel Y. (2007) PLoS Computational Biology. 3, 7, p. 1291-1304  Abstract
190.
Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z. & Oren M. (2007) Molecular Cell. 26, 5, p. 731-743  Abstract
189.
Weisz L., Oren M. & Rotter V. (2007) Oncogene. 26, 15, p. 2202-2211  Abstract
188.
Weisz L., Damalas A., Liontos M. et al. (2007) Cancer Research. 67, 6, p. 2396-2401  Abstract [All authors]
187.
Oren M. & Bartek J. (2007) Cell. 128, 5, p. 826-828  Abstract
186.
Shmueli A. & Oren M. (2007) Molecular Cell. 25, 6, p. 794-796  Abstract

2006

185.
Stambolsky P., Weisz L., Shats I., Klein Y. A., Goldfinger N., Oren M. & Rotter V. (2006) Cell Death and Differentiation. 13, 12, p. 2140-2149  Abstract
184.
Oren M. (2006) Ejc Supplements. 4, 12, p. 76-76  Abstract
183.
Moskovits N., Kalinkovich A., Bar J. & Oren M. (2006) Cancer Research. 66, 22, p. 10671-10676  Abstract
182.
Aylon Y., Michael D., Shmueli A., Yabuta N., Nojima H. & Oren M. (2006) GENES & DEVELOPMENT. 20, 19, p. 2687-2700  Abstract
181.
Rentsch C. A., Germann M., Wetterwald A. et al. (2006) European Urology Supplements. 5, 14, p. 790-790  Abstract
[All authors]
180.
Avkin S., Sevilya Z., Toube L., Geacintov N., Chaney S., Oren M. & Livneh Z. (2006) Molecular Cell. 22, 3, p. 407-413  Abstract
179.
Reef S., Zalckvar E., Shifman O., Bialik S., Sabanay H., Oren M. & Kimchi A. (2006) Molecular Cell. 22, 4, p. 463-475  Abstract
178.
Kogan I., Goldfinger N., Milyavsky M. et al. (2006) Cancer Research. 66, 7, p. 3531-3540  Abstract
[All authors]
177.
Margalit O., Amram H., Amariglio N. et al. (2006) Blood. 107, 4, p. 1599-1607  Abstract [All authors]
176.
Zalcenstein A., Weisz L., Stambolsky P., Bar J., Rotter V. & Oren M. (2006) Oncogene. 25, 3, p. 359-369  Abstract

2005

175.
Bar J., Lukaschuk N., Zalcenstein A., Wilder S., Seger R. & Oren M. (2005) Cell Death and Differentiation. 12, 12, p. 1578-1587  Abstract
174.
Muller M., Schilling T., Sayan A. et al. (2005) Cell Death and Differentiation. 12, 12, p. 1564-1577  Abstract [All authors]
173.
Gressner O., Schilling T., Lorenz K. et al. (2005) EMBO Journal. 24, 13, p. 2458-2471  Abstract [All authors]
172.
Shmueli A. & Oren M. (2005) Cell. 121, 7, p. 963-965  Abstract
171.
Oberst A., Rossi M., Salornoni P., Pandolfi P., Oren M., Melino G. & Bernassola F. (2005) Biochemical and Biophysical Research Communications. 331, 3, p. 707-712  Abstract
170.
Hershko T., Chaussepied M., Oren M. & Ginsberg D. (2005) Cell Death and Differentiation. 12, 4, p. 377-383  Abstract
169.
Wohlbold L., van der Kuip d. K. H., Moehring A., Granot G., Oren M., Vornlocher H. & Aulitzky W. (2005) Leukemia. 19, 2, p. 290-292  Abstract
168.
Damalas A., Weis L., Nordgard S. et al. (2005) Breast Cancer Research. 7, p. S53-S53  Abstract
[All authors]

2004

167.
Minsky N. & Oren M. (2004) Molecular Cell. 16, 4, p. 631-639  Abstract
166.
Weisz L., Zalcenstein A., Stambolsky P., Cohen Y., Goldfinger N., Oren M. & Rotter V. (2004) Cancer Research. 64, 22, p. 8318-8327  Abstract
165.
Daniely Y., Liao G., Dixon D., Linnoila R., Lori A., Randell S., Oren M. & Jetten A. (2004) American Journal Of Physiology-Cell Physiology. 287, 1, p. C171-C181  Abstract
164.
Levina E., Oren M. & Ben-Ze'ev A. (2004) Oncogene. 23, 25, p. 4444-4453  Abstract
163.
Bar J., Cohen-Noyman E., Geiger B. & Oren M. (2004) Oncogene. 23, 12, p. 2128-2137  Abstract
162.
Wang X., Taplick J., Geva N. & Oren M. (2004) FEBS Letters. 561, 3-Jan, p. 195-201  Abstract
161.
Fiucci G., Beaucourt S., Duflaut D. et al. (2004) Proceedings of the National Academy of Sciences of the United States of America. 101, 10, p. 3510-3515  Abstract
[All authors]
160.
Shmueli A. & Oren M. (2004) Molecular Cell. 13, 1, p. 4-5  Abstract

2003

159.
Zalcenstein A., Stambolsky P., Weisz L., Muller M., Wallach D., Goncharov T., Krammer P., Rotter V. & Oren M. (2003) Oncogene. 22, 36, p. 5667-5676  Abstract
158.
Ofek P., Ben-Meir D., Kariv-Inbal Z., Oren M. & Lavi S. (2003) Journal of Biological Chemistry. 278, 16, p. 14299-14305  Abstract
157.
Oren M. (2003) Cell Death and Differentiation. 10, 4, p. 431-442  Abstract
156.
Wang X., Zalcenstein A. & Oren M. (2003) Cell Death and Differentiation. 10, 4, p. 468-476  Abstract
155.
Passer B., Nancy-Portebois V., Amzallag N. et al. (2003) Proceedings of the National Academy of Sciences of the United States of America. 100, 5, p. 2284-2289  Abstract [All authors]
154.
Michael D. Y. & Oren M. (2003) Seminars in Cancer Biology. 13, 1, p. 49-58  Abstract
153.
Nuclear factor-kappa B protects the liver against genotoxic stress and functions independently of p53
Lavon I., Pikarsky E., Gutkovich E., Goldberg I., Bar J., Oren M. & Ben-Neriah Y. (2003) Cancer Research. 63, 1, p. 25-30  Abstract

2002

152.
Blander G., Zalle N., Daniely Y., Taplick J., Gray M. & Oren M. (2002) Journal of Biological Chemistry. 277, 52, p. 50934-50940  Abstract
151.
OREN M., DAMALAS A., GOTTLIEB T. et al. (2002) Annals of the New York Academy of Sciences. 973, 1, p. 374-383  Abstract
[All authors]
150.
Courtois S., Verhaegh G., North S., Luciani M., Lassus P., Hibner U., Oren M. & Hainaut P. (2002) Oncogene. 21, 44, p. 6722-6728  Abstract
149.
Balass M., Kalef E., Maya R., Wilder S., Oren M. & Katchalski-Katzir E. (2002) Peptides. 23, 10, p. 1719-1725  Abstract
148.
Shtutman M., Zhurinsky J., Oren M., Levina E. & Ben-Ze'ev A. (2002) Cancer Research. 62, 20, p. 5947-5954  Abstract
147.
Goldberg Z., Vogt Sionov S. R., Berger M., Zwang Y., Perets R., Van Etten E. R., Oren M., Taya Y. & Haupt Y. (2002) EMBO Journal. 21, 14, p. 3715-3727  Abstract
146.
Wang X., Michael D. Y., de Murcia M. G. & Oren M. (2002) Journal of Biological Chemistry. 277, 18, p. 15697-15702  Abstract
145.
Strano S., Fontemaggi G., Costanzo A. et al. (2002) Journal of Biological Chemistry. 277, 21, p. 18817-18826  Abstract [All authors]
144.
Folberg-Blum A., Sapir A., Shilo B. & Oren M. (2002) Oncogene. 21, 15, p. 2413-2417  Abstract
143.
Michael D. Y. & Oren M. (2002) Current opinion in genetics & development. 12, 1, p. 53-59  Abstract
142.
Gottlieb T., Leal J., Seger R., Taya Y. & Oren M. (2002) Oncogene. 21, 8, p. 1299-1303  Abstract

2001

141.
Susini L., Passer B., Amzallag-Elbaz N. et al. (2001) Proceedings of the National Academy of Sciences of the United States of America. 98, 26, p. 15067-15072  Abstract
[All authors]
140.
Requirement for Mdm2 in the survival effects of Bcr-Abl and interleukin 3 in hematopoietic cells
Goetz A., van der Kuip d. K. H., Maya R., Oren M. & Aulitzky W. (2001) Cancer Research. 61, 20, p. 7635-7641  Abstract
139.
Sadot E., Geiger B., Oren M. & Ben-Ze'ev A. (2001) Molecular and Cellular Biology. 21, 20, p. 6768-6781  Abstract
138.
Damalas A., Kahan S., Shtutman M., Ben-Ze'ev A. & Oren M. (2001) EMBO Journal. 20, 17, p. 4912-4922  Abstract
137.
Strano S., Munarriz E., Rossi M. et al. (2001) Journal of Biological Chemistry. 276, 18, p. 15164-15173  Abstract [All authors]
136.
Maya R., Balass M., Kim S. et al. (2001) GENES & DEVELOPMENT. 15, 9, p. 1067-1077  Abstract [All authors]

2000

135.
Reinstein E., Scheffner M., Oren M., Ciechanover A. & Schwartz A. (2000) Oncogene. 19, 51, p. 5944-5950  Abstract
134.
The Warner syndrome protein contributes to induction of p53 by DNA damage
Blander G., Zalle N., Leal J., Bar-Or R., Yu C. & Oren M. (2000) FASEB Journal. 14, 14, p. 2138-2140  Abstract
133.
Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study
Bar-Or R., Maya R., Segel L., Alon U., Levine A. & Oren M. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 21, p. 11250-11255  Abstract
132.
Ries S., Biederer C., Woods D., Shifman O., Shirasawa S., Sasazuki T., McMahon M., Oren M. & McCormick F. (2000) Cell. 103, 2, p. 321-330  Abstract
131.
Strano S., Munarriz E., Rossi M. et al. (2000) Journal of Biological Chemistry. 275, 38, p. 29503-29512  Abstract [All authors]
130.
Maya R. & Oren M. (2000) Oncogene. 19, 28, p. 3213-3215  Abstract
129.
Amson R., Lassalle J., Halley H. et al. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 10, p. 5346-5350  Abstract
[All authors]
128.
de Rozieres R. S., Maya R., Oren M. & Lozano G. (2000) Oncogene. 19, 13, p. 1691-1697  Abstract

1999

127.
Khosravi R., Maya R., Gottlieb T., Oren M., Shiloh Y. & Shkedy D. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 26, p. 14973-14977  Abstract
126.
Oren M. (1999) Journal of Biological Chemistry. 274, 51, p. 36031-36034  Abstract
125.
Blander G., Kipnis J., Leal J., Yu C., Schellenberg G. & Oren M. (1999) Journal of Biological Chemistry. 274, 41, p. 29463-29469  Abstract
124.
Roperch J., Lethrone F., Prieur S. et al. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 14, p. 8070-8073  Abstract
[All authors]
123.
Interaction of c-Abl and p73 alpha and their collaboration to induce apoptosis
Agami R., Blandino G., Oren M. & Shaul Y. (1999) Nature. 399, 6738, p. 809-813  Abstract
122.
Damalas A., Ben-Ze'ev A., Simcha I., Shtutman N., Leal J., Zhurinsky J., Geiger B. & Oren M. (1999) EMBO Journal. 18, 11, p. 3054-3063  Abstract
121.
Hot papers - Cancer research - Mdm2 promotes the rapid degradation of p53 by Y. Haupt, R. Maya, A. Kazaz, M. Oren and Regulation of p53 stability by Mdm2 by M.H.G. Kubbutat, S.N. Jones, K.H. Vousden - Comments
Oren M. & Vousden K. (1999) Scientist. 13, 12, p. 11-11  Abstract
120.
MDM2 suppresses p73 function without promoting p73 degradation
Zeng X., Chen L., Jost C. et al. (1999) Molecular and Cellular Biology. 19, 5, p. 3257-3266  Abstract [All authors]
119.
Unger T., Sionov R., Moallem E., Yee C., Howley P., Oren M. & Haupt Y. (1999) Oncogene. 18, 21, p. 3205-3212  Abstract
118.
The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor
Elkeles A., Juven-Gershon T., Israeli D., Wilder S., Zalcenstein A. & Oren M. (1999) Molecular and Cellular Biology. 19, 4, p. 2594-2600  Abstract
117.
Unger T., Juven-Gershon T., Moallem E., Berger M., Sionov R., Lozano G., Oren M. & Haupt Y. (1999) EMBO Journal. 18, 7, p. 1805-1814  Abstract
116.
Sionov R., Moallem E., Berger M., Kazaz A., Gerlitz O., Ben-Neriah Y., Oren M. & Haupt Y. (1999) Journal of Biological Chemistry. 274, 13, p. 8371-8374  Abstract
115.
Mdm2: The ups and downs
Juven-Gershon T. & Oren M. (1999) Molecular Medicine. 5, 2, p. 71-83  Abstract
114.
Blandino G., Levine A. & Oren M. (1999) Oncogene. 18, 2, p. 477-485  Abstract
113.
Oren M. & Rotter V. (1999) Cellular and Molecular Life Sciences. 55, 1, p. 9-11  Abstract

1998

112.
Muller M., Wilder S., Bannasch D. et al. (1998) Journal of Experimental Medicine. 188, 11, p. 2033-2045  Abstract [All authors]
111.
Hosokawa K., Aharoni D., Dantes A. et al. (1998) Endocrinology. 139, 11, p. 4688-4700  Abstract
[All authors]
110.
Gottlieb T. & Oren M. (1998) Seminars in Cancer Biology. 8, 5, p. 359-368  Abstract
109.
Wang Y., Blandino G., Oren M. & Givol D. (1998) Oncogene. 17, 15, p. 1923-1930  Abstract
108.
Gottlieb E. & Oren M. (1998) EMBO Journal. 17, 13, p. 3587-3596  Abstract
107.
Yardley G., Zauberman A., Oren M. & Jackson P. (1998) FEBS Letters. 430, 3, p. 171-175  Abstract
106.
The Mdm2 oncoprotein interacts with the cell fate regulator numb
Juven-Gershon T., Shifman O., Unger T., Elkeles A., Haupt Y. & Oren M. (1998) Molecular and Cellular Biology. 18, 7, p. 3974-3982  Abstract
105.
Roperch J., Alvaro V., Prieur S. et al. (1998) Nature Medicine. 4, 7, p. 835-838  Abstract
[All authors]
104.
Oren M. (1998) Nature. 391, 6664, p. 233-234  Abstract
103.
Ori A., Zauberman A., Doitsh G., Paran N., Oren M. & Shaul Y. (1998) EMBO Journal. 17, 2, p. 544-553  Abstract

1997

102.
Shaulian E., Resnitzky D., Shifman O., Blandino G., Amsterdam A., Yayon A. & Oren M. (1997) Oncogene. 15, 22, p. 2717-2725  Abstract
101.
Zauberman A., Oren M. & Zipori D. (1997) Oncogene. 15, 14, p. 1705-1711  Abstract
99.
Friedman S., Shaulian E., Littlewood T., Resnitzky D. & Oren M. (1997) Oncogene. 15, 1, p. 63-70  Abstract
98.
Israeli D., Tessler E., Haupt Y., Elkeles A., Wilder S., Amson R., Telerman A. & Oren M. (1997) EMBO Journal. 16, 14, p. 4384-4392  Abstract
97.
Haupt Y., Maya R., Kazaz A. & Oren M. (1997) Nature. 387, 6630, p. 296-299  Abstract
96.
Ruaro E., Collavin L., DelSal G., Haffner R., Oren M., Levine A. & Schneider C. (1997) Proceedings of the National Academy of Sciences of the United States of America. 94, 9, p. 4675-4680  Abstract
95.
Gottlieb E., Haffner R., King A., Asher G., Gruss P., Lonai P. & Oren M. (1997) EMBO Journal. 16, 6, p. 1381-1390  Abstract
94.
Hansen R. & Oren M. (1997) Current opinion in genetics & development. 7, 1, p. 46-51  Abstract

1996

93.
Oren M. & Prives C. (1996) Biochimica Et Biophysica Acta-Reviews On Cancer. 1288, 3, p. R13-R19  Abstract
92.
Friedlander P., Haupt Y., Prives C. & Oren M. (1996) Molecular and Cellular Biology. 16, 9, p. 4961-4971  Abstract
91.
p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells
Eizenberg O., FaberElman A., Gottlieb E., Oren M., Rotter V. & Schwartz M. (1996) Molecular and Cellular Biology. 16, 9, p. 5178-5185  Abstract
90.
Tanaka N., Ishihara M., Lamphier M. et al. (1996) Nature. 382, 6594, p. 816-818  Abstract
[All authors]
89.
Nemani M., LinaresCruz G., BruzzoniGiovanelli H. et al. (1996) Proceedings of the National Academy of Sciences of the United States of America. 93, 17, p. 9039-9042  Abstract
[All authors]
88.
Gottlieb T. & Oren M. (1996) Biochimica Et Biophysica Acta-Reviews On Cancer. 1287, 3-Feb, p. 77-102  Abstract
87.
Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells
Bacus S., Yarden Y., Oren M. et al. (1996) Oncogene. 12, 12, p. 2535-2547  Abstract
[All authors]
86.
Bowman T., Symonds H., Gu L., Yin C., Oren M. & VanDyke T. (1996) GENES & DEVELOPMENT. 10, 7, p. 826-835  Abstract
85.
Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion
Knippschild U., Oren M. & Deppert W. (1996) Oncogene. 12, 8, p. 1755-1765  Abstract
84.
Haupt Y., Barak Y. & Oren M. (1996) EMBO Journal. 15, 7, p. 1596-1606  Abstract
83.
Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells
Gottlieb E., Lindner S. & Oren M. (1996) Cell Growth & Differentiation. 7, 3, p. 301-310  Abstract
82.
Rowan S., Ludwig R., Haupt Y., Bates S., Lu X., Oren M. & Vousden K. (1996) EMBO Journal. 15, 4, p. 827-838  Abstract
81.
p53-Mediated apoptosis - Regulatory and mechanistic aspects
Haupt Y., Rowan S., Shaulian E., Gottlieb E., YonishRouach E., Vousden K. & Oren M. (1996) Cancer Genes: Functional Aspects. 7, p. 83-101  Abstract

1995

80.
E2F-1/DP-1 INDUCES P53 AND OVERRIDES SURVIVAL FACTORS TO TRIGGER APOPTOSIS
HIEBERT S., PACKHAM G., STROM D., HAFFNER R., Oren M., ZAMBETTI G. & CLEVELAND J. (1995) Molecular and Cellular Biology. 15, 12, p. 6864-6874  Abstract
79.
STUART E., HAFFNER R., Oren M. & GRUSS P. (1995) EMBO Journal. 14, 22, p. 5638-5645  Abstract
78.
Cancer: The translation of advances in basic science to human therapy. 22-27 July, 1995 - La fondation des Treilles, Tourtour, France - Discussion
Harlow E., Tlsty T., Courtneidge S. et al. (1995) Comptes Rendus De L Academie Des Sciences Serie Iii-Sciences De La Vie-Life Sciences. 318, 11, p. 1173-1179  Abstract
[All authors]
77.
MALCOMSON R., Oren M., WYLLIE A. & HARRISON D. (1995) British Journal of Cancer. 72, 4, p. 952-957  Abstract
76.
HAUPT Y., ROWAN S., SHAULIAN E., VOUSDEN K. & Oren M. (1995) GENES & DEVELOPMENT. 9, 17, p. 2170-2183  Abstract
75.
Zauberman A., FLUSBERG D., HAUPT Y., Barak Y. & Oren M. (1995) Nucleic Acids Research. 23, 14, p. 2584-2592  Abstract